Caas Capital Management LP Abbott Laboratories Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.1 Million - $1.32 Million	11,500 New	11,500 $1.11 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $669,593 - $788,151	6,913 New	6,913 $700,000
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $1.05 Million - $1.23 Million	-9,899 Reduced 69.47%	4,351 $504,000
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $3.06 Million - $3.71 Million	-33,350 Reduced 70.06%	14,250 $1.55 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $3.64 Million - $4.66 Million	47,600 New	47,600 $4.35 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.